131 related articles for article (PubMed ID: 8417790)
1. Mode of action of iron (III) chelators as antimalarials: I. Membrane permeation properties and cytotoxic activity.
Lytton SD; Mester B; Dayan I; Glickstein H; Libman J; Shanzer A; Cabantchik ZI
Blood; 1993 Jan; 81(1):214-21. PubMed ID: 8417790
[TBL] [Abstract][Full Text] [Related]
2. Mode of action of iron(III) chelators as antimalarials. III. Overadditive effects in the combined action of hydroxamate-based agents on in vitro growth of Plasmodium falciparum.
Tsafack A; Golenser J; Libman J; Shanzer A; Cabantchik ZI
Mol Pharmacol; 1995 Feb; 47(2):403-9. PubMed ID: 7870051
[TBL] [Abstract][Full Text] [Related]
3. Chemical Determinants of antimalarial activity of reversed siderophores.
Tsafack A; Libman J; Shanzer A; Cabantchik ZI
Antimicrob Agents Chemother; 1996 Sep; 40(9):2160-6. PubMed ID: 8878599
[TBL] [Abstract][Full Text] [Related]
4. Iron chelators: mode of action as antimalarials.
Cabantchik ZI; Glickstein H; Golenser J; Loyevsky M; Tsafack A
Acta Haematol; 1996; 95(1):70-7. PubMed ID: 8604590
[TBL] [Abstract][Full Text] [Related]
5. Mode of action of iron (III) chelators as antimalarials: II. Evidence for differential effects on parasite iron-dependent nucleic acid synthesis.
Lytton SD; Mester B; Libman J; Shanzer A; Cabantchik ZI
Blood; 1994 Aug; 84(3):910-5. PubMed ID: 8043872
[TBL] [Abstract][Full Text] [Related]
6. Chelation of iron within the erythrocytic Plasmodium falciparum parasite by iron chelators.
Loyevsky M; John C; Dickens B; Hu V; Miller JH; Gordeuk VR
Mol Biochem Parasitol; 1999 Jun; 101(1-2):43-59. PubMed ID: 10413042
[TBL] [Abstract][Full Text] [Related]
7. The antimalarial action of desferal involves a direct access route to erythrocytic (Plasmodium falciparum) parasites.
Loyevsky M; Lytton SD; Mester B; Libman J; Shanzer A; Cabantchik ZI
J Clin Invest; 1993 Jan; 91(1):218-24. PubMed ID: 8423220
[TBL] [Abstract][Full Text] [Related]
8. Reversed siderophores as antimalarial agents. II. Selective scavenging of Fe(III) from parasitized erythrocytes by a fluorescent derivative of desferal.
Lytton SD; Cabantchik ZI; Libman J; Shanzer A
Mol Pharmacol; 1991 Oct; 40(4):584-90. PubMed ID: 1921988
[TBL] [Abstract][Full Text] [Related]
9. Reversed siderophores act as antimalarial agents.
Shanzer A; Libman J; Lytton SD; Glickstein H; Cabantchik ZI
Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6585-9. PubMed ID: 1862083
[TBL] [Abstract][Full Text] [Related]
10. Differential cytotoxicity of iron chelators on malaria-infected cells versus mammalian cells.
Glickstein H; Breuer W; Loyevsky M; Konijn AM; Shanzer A; Cabantchik ZI
Blood; 1996 Jun; 87(11):4871-8. PubMed ID: 8639861
[TBL] [Abstract][Full Text] [Related]
11. Mode of action of iron (III) chelators as antimalarials. IV. Potentiation of desferal action by benzoyl and isonicotinoyl hydrazone derivatives.
Tsafack A; Loyevsky M; Ponka P; Cabantchik ZI
J Lab Clin Med; 1996 Jun; 127(6):574-82. PubMed ID: 8648262
[TBL] [Abstract][Full Text] [Related]
12. Antimalarial action of hydroxamate-based iron chelators and potentiation of desferrioxamine action by reversed siderophores.
Golenser J; Tsafack A; Amichai Y; Libman J; Shanzer A; Cabantchik ZI
Antimicrob Agents Chemother; 1995 Jan; 39(1):61-5. PubMed ID: 7695330
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometric assessment of hydroxypyridinone iron chelators on in vitro growth of drug-resistant malaria.
Pattanapanyasat K; Thaithong S; Kyle DE; Udomsangpetch R; Yongvanitchit K; Hider RC; Webster HK
Cytometry; 1997 Jan; 27(1):84-91. PubMed ID: 9000589
[TBL] [Abstract][Full Text] [Related]
14. Iron chelators as antimalarial agents: in vitro activity of dicatecholate against Plasmodium falciparum.
Pradines B; Rolain JM; Ramiandrasoa F; Fusai T; Mosnier J; Rogier C; Daries W; Baret E; Kunesch G; Le Bras J; Parzy D
J Antimicrob Chemother; 2002 Aug; 50(2):177-87. PubMed ID: 12161397
[TBL] [Abstract][Full Text] [Related]
15. The combined effect of iron chelators and classical antimalarials on the in-vitro growth of Plasmodium falciparum.
van Zyl RL; Havlik I; Monteagudo FS
J Antimicrob Chemother; 1992 Sep; 30(3):273-8. PubMed ID: 1452491
[TBL] [Abstract][Full Text] [Related]
16. In vitro antimalarial effect of daphnetin relating to its iron-chelating activity.
Mu LY; Wang QM; Ni YC
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2002; 20(2):83-5. PubMed ID: 12567565
[TBL] [Abstract][Full Text] [Related]
17. Antimalarial properties of orally active iron chelators.
Heppner DG; Hallaway PE; Kontoghiorghes GJ; Eaton JW
Blood; 1988 Jul; 72(1):358-61. PubMed ID: 3291984
[TBL] [Abstract][Full Text] [Related]
18. Antimalarial effect of iron chelators.
Gordeuk VR; Loyevsky M
Adv Exp Med Biol; 2002; 509():251-72. PubMed ID: 12572998
[No Abstract] [Full Text] [Related]
19. Effects of hydroxypyridinone iron chelators in combination with antimalarial drugs on the in vitro growth of Plasmodium falciparum.
Pattanapanyasat K; Kotipun K; Yongvanitchit K; Hider RC; Kyle DE; Heppner DG; Walsh DS
Southeast Asian J Trop Med Public Health; 2001 Mar; 32(1):64-9. PubMed ID: 11485097
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and antimalarial activity of a new class of iron chelators.
Solomon VR; Haq W; Puri SK; Srivastava K; Katti SB
Med Chem; 2006 Mar; 2(2):133-8. PubMed ID: 16787362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]